Are you Dr. Levy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- Dr. Ronald Levy, MD is an oncologist in Stanford, California. He is currently licensed to practice medicine in California. He is a Professor at Stanford University Medical Center.
Education & Training
Stanford University School of MedicineClass of 1968
Certifications & Licensure
CA State Medical License 1972 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A Phase I Clinical Trial Adding OX40 Agonism to In Situ Therapeutic Cancer Vaccination in Patients with Low-Grade B-cell Lymphoma Highlights Challenges in Translation ...Tanaya Shree, Debra Czerwinski, Sarah Haebe, Anuja Sathe, Sue Grimes
Clinical Cancer Research. 2025-03-03 - 3 citationsIsoprenoid CARTs:andmRNA Delivery by Charge-Altering Releasable Transporters Functionalized with Archaea-inspired Branched Lipids.Harrison P Rahn, Jiuzhi Sun, Zhijian Li, Robert M Waymouth, Ronald Levy
Biomacromolecules. 2024-07-08 - 1 citationsA clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis.Tanaya Shree, Sarah Haebe, Debra K Czerwinski, Erik Eckhert, Grady Day
Blood Advances. 2024-01-09
Press Mentions
Prior Treatment with Cancer Drug Likely Renders COVID-19 Vaccine Ineffective, Study FindsFebruary 2nd, 2022- How COVID-19 Vaccine Strategy Could Combat Other DiseasesDecember 18th, 2020
Science in the 2010s – MedicineDecember 26th, 2019- Join now to see all
Grant Support
- Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation modelsTEMPLE UNIV OF THE COMMONWEALTH2023–2028
- Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation modelsTEMPLE UNIV OF THE COMMONWEALTH2023–2028
- Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation modelsTEMPLE UNIV OF THE COMMONWEALTH2023–2028
- Mapping Fitness & Free Energy Landscapes of ProteinsTEMPLE UNIV OF THE COMMONWEALTH2019–2027
- Mapping Fitness & Free Energy Landscapes of ProteinsTEMPLE UNIV OF THE COMMONWEALTH2019–2027
- Mapping Fitness & Free Energy Landscapes of ProteinsTEMPLE UNIV OF THE COMMONWEALTH2019–2027
- Mapping Fitness & Free Energy Landscapes of ProteinsTEMPLE UNIV OF THE COMMONWEALTH2019–2027
- Imaging Modulation of Immune PhenotypeSTANFORD UNIVERSITY2021–2026
- Imaging Modulation of Immune PhenotypeSTANFORD UNIVERSITY2021–2026
- New Materials to Deliver mRNA: Applications in Cancer ImmunotherapySTANFORD UNIVERSITY2020–2025
